(Q44123892)

30 November 2017

1 reference

title

Drug addictions: towards socially accepted and medically treatable diseases (English)

1 reference

30 November 2017

Philippe Pouletty

1

1 reference

30 November 2017

publication date

1 September 2002

1 reference

Nature Reviews Drug Discovery

30 November 2017

published in

1 reference

30 November 2017

volume

1

1 reference

30 November 2017

issue

9

1 reference

30 November 2017

page(s)

731-736

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd896

30 November 2017

exact match

0 references

cites work

Morbidity and mortality attributable to alcohol, tobacco, and illicit drug use in Canada.

1 reference

Molecular neurobiology of addiction

21 January 2018

1 reference

Alcohol dependence: a public health perspective

21 January 2018

1 reference

Alcohol, tobacco, and drug use among young adults prior to entering the military.

21 January 2018

1 reference

Increasing MDMA use among college students: results of a national survey

21 January 2018

1 reference

Costs of drug abuse to society

21 January 2018

1 reference

The costs of drug abuse consequences: a summary of research findings.

21 January 2018

1 reference

Economic cost of alcohol and drug abuse in the United States, 1992: a report.

21 January 2018

1 reference

Estimating the costs of substance abuse to the Medicaid hospital care program.

21 January 2018

1 reference

The economic costs of heroin addiction in the United States

21 January 2018

1 reference

Social costs of untreated opioid dependence

21 January 2018

1 reference

Economic burden of drug dependency. Social costs incurred by drug users at intake to the National Treatment Outcome Research Study.

21 January 2018

1 reference

Treatment of heroin (diamorphine) addiction: current approaches and future prospects

21 January 2018

1 reference

Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis

21 January 2018

1 reference

Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment

21 January 2018

1 reference

Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial

21 January 2018

1 reference

Can alcohol price policies be used to reduce drunk driving? Evidence from Canada

21 January 2018

1 reference

Buprenorphine suppresses heroin use by heroin addicts

21 January 2018

1 reference

Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans

21 January 2018

1 reference

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

21 January 2018

1 reference

gamma-aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine.

21 January 2018

1 reference

A second-generation vaccine protects against the psychoactive effects of cocaine

21 January 2018

1 reference

Cocaine treatment increases extracellular cholecystokinin (CCK) in the nucleus accumbens shell of awake, freely moving rats, an effect that is enhanced in rats that are behaviorally sensitized to cocaine

21 January 2018

1 reference

Risperidone for the treatment of cocaine dependence: randomized, double-blind trial.

21 January 2018

1 reference

Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial

21 January 2018

1 reference

Effects of the calcium antagonist isradipine on cocaine intravenous self-administration in rats.

21 January 2018

1 reference

Haloperidol antagonism of cue-elicited cocaine craving

21 January 2018

1 reference

Adrogolide HCl (ABT-431; DAS-431), a prodrug of the dopamine D1 receptor agonist, A-86929: preclinical pharmacology and clinical data

21 January 2018

1 reference

Alcohol abuse and dependence among U.S. college students

21 January 2018

1 reference

Buprenorphine and naloxone interactions in opiate-dependent volunteers*

21 January 2018

1 reference

Alcoholism. The cost of illness in the Federal Republic of Germany

21 January 2018

1 reference

Naltrexone and alcohol dependence. Role of subject compliance

21 January 2018

1 reference

Does increased spending on alcoholism treatment lead to lower cirrhosis death rates?

21 January 2018

1 reference

D(1) receptors in prefrontal cells and circuits

21 January 2018

1 reference

Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation

21 January 2018

1 reference

The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992.

21 January 2018

1 reference

The social costs of alcohol abuse in New Zealand

31 March 2020

1 reference

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

31 March 2020

1 reference

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD896

1 reference

30 November 2017

1 reference